0
Regulus Therapeutics
- 51-200 Employees
- Based in San Diego, California
Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property…More
Regulus Therapeutics
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Report Locked. Regulus Therapeutics has reached its limit for free report views.
